The influence of dose differences of remifentanil to renal functions in perioperative patients with chronic kidney disease

The influence of dose differences of remifentanil to renal functions in perioperative patients with chronic kidney disease - The influence of dose differences of remifentanil to renal functions in perioperative patients with chronic kidney disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011298

Enrollment

Registered

2013-07-27

Start date

2013-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioparative adult patients with chronic kidney disease(CKD) undergoing orthopedic surgery

Interventions

Remifentanil 1 microgram/kg/min Remifentanil 0.5 microgram/kg/min Remifentanil 0.25 microgram/kg/min

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Perioperative adult patients with CKD (CKD GFR stage 3: 30 =< eGFRcreat < 60) undergoing total hip arthroplasty(THA) or total knee arthroplasty

Exclusion criteria

Exclusion criteria: Patients with preoparative heart failure, severe valvular disease, not sinus rhythm and obesity(BMI >= 30)

Design outcomes

Primary

Measure	Time frame
estimated glomerular filtratin rate(eGFR)	—

Countries

Japan

Contacts

Public ContactTakerou Terashi

Kagoshima Red Cross Hospital Department of anesthesiology

terashi@m2.kufm.kagoshima-u.ac.jp099-261-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026